Fitterfly HealthTech Pvt Ltd Logo
< Back to Listing
Conference abstracts Conference abstracts
Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on Diabefly® digital therapeutics program using multidisciplinary approach
Dec 2021 | Poster | By Dr Ritika Verma, Sanjay Kalra, Kirti Samudra, Piya Ballani, Vandana Jain, Akshata Agnihotri, Jitendra Ajmera, Amit Saraf, Sneha Kothari, Ashish Sarawte, Dr Arbinder Kumar Singal

Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on Diabefly® digital therapeutics program using multidisciplinary approach

Long-term hyperglycemia is a potential risk factor for both macro and microvascular complications. This study demonstrated the effectiveness of the Diabefly® program in participants with poorly controlled Type 2 diabetes, which is evident from the results of 49 participants showing an effective reduction in HbA1C, body weight and BMI by 3.34%, 2.41 kg and 0.82 kg/m2 from the baseline respectively. Similarly, a crucial mean reduction in waist circumference, carbohydrate and total calorie intake was observed among participants with respective complete data from the baseline.

Read full paper